Cubresa has expanded our Master Interface Agreement with Siemens Healthineers to include the Biograph One™ MR.
February 5, 2026 Master Interface Agreement with Siemens Healthineers to include the Biograph One™ MR. Winnipeg, MB – February 5th, 2025 We are pleased to announce that Cubresa has expanded our Master Interface Agreement with Siemens Healthineers to include the Biograph One™ MR. This expansion marks a significant step forward in our mission to bring simultaneous
Cubresa Files First FDA 510(k) Application
Cubresa Files First FDA 510(k) Application Cubresa Inc. is pleased to announce the company has submitted the Cubresa BrainPET™ 510(k) Premarket Notification to the Food and Drug Administration (FDA) This submission marks a pivotal step in our company’s mission to bring world-class brain imaging technology into clinical settings,” remarked James Schellenberg, Cubresa’s Founder and CEO,
Cubresa and Siemens Healthineers Sign Global Master Interface Agreement for the Cubresa BrainPET™ Scanner
February 11th, 2025 Cubresa and Siemens Healthineers Sign Global Master Interface Agreement for the Cubresa BrainPET™ Scanner Winnipeg, MB – February 11th, 2025 – Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract designed to support development efforts and compatibility testing
The Neuro (Montreal Neurological Institute-Hospital) at McGill University Selects Cubresa’s BrainPET for 7T Brain Research Program
June 26, 2024 The Neuro (Montreal Neurological Institute-Hospital) at McGill University Selects Cubresa’s BrainPET for 7T Brain Research Program Winnipeg, MB – June 26, 2024 – The Neuro (Montreal Neurological Institute-Hospital) at McGill University has selected Cubresa’s investigational BrainPET scanner to enhance their 7T MRI research program. This will be the first installation into a
Cubresa Installs First BrainPET Insert System at Lawson Health Research Institute
Tuesday, May 30th, 2023 PRESS RELEASE Cubresa Installs First BrainPET Insert System at Lawson Health Research Institute Winnipeg, MB – May 30th, 2023 – Cubresa has installed the first BrainPET Insert System at St. Joseph’s Health Care London, in partnership with the hospital’s research institute – Lawson Health Research Institute. The Cubresa BrainPET is a
Cubresa Announces the Appointment of 2 New Board Members
Tuesday, November 29th, 2022 PRESS RELEASE Cubresa Appoints Mr. Ryan Klassen and Ms. Trudy Martens to Board of Directors Winnipeg, MB – November 29th, 2022 – Cubresa Inc., a world leader in brain imaging, is announcing two 2 appointments to its board of directors, Mr. Ryan Klassen, and Ms. Trudy Martens. “The directors and I are
Cubresa Appoints Ms. Leah Friesen as Director of Operations
Tuesday, April 5th, 2022 PRESS RELEASE Cubresa Appoints Ms. Leah Friesen as Director of Operations Winnipeg, MB – April 5th, 2022 – Cubresa Inc., a world leader in the design and development of PET insert systems for MRI, is announcing a new senior appointment within the company, Ms. Leah Friesen as the Director of Operations. “Cubresa’s
Case Western Reserve University selects Cubresa’s NuPET™ System to Support Preclinical Research Activities
Wednesday, February 16th, 2022 PRESS RELEASE Case Western Reserve University selects Cubresa’s NuPET™ System to Support Preclinical Research Activities Winnipeg, MB – February 16th, 2022 – Case Western Reserve University (CWRU) has selected Cubresa’s Preclinical NuPET™ Insert System to add to their suite of imaging tools. The NuPET 66 will support research in a wide
Barrow Neurological Institute selects Cubresa’s BrainPET system to support neurological research activities
Barrow Neurological Institute selects Cubresa’s BrainPET system to support neurological research activities Winnipeg, MB – January 5th, 2022 – Barrow Neurological Institute, the world’s largest neurological disease treatment and research institution, in conjunction with Arizona State University (ASU), have selected Cubresa’s BrainPET system to add to their suite of imaging tools. A joint acquisition between Barrow
Recognizing Dr. Sheryl Herrera
Cubresa is pleased to recognize the work of our colleague, Dr. Sheryl Herrera, who has been recently published in ScienceDirect – Axon diameter inferences in the human corpus callosum using oscillating gradient spin echo sequences – link here – https://www.sciencedirect.com/science/article/abs/pii/S0730725X21001818#ab0005 . University of Winnipeg article here – https://news.uwinnipeg.ca/researchers-develop-new-way-to-measure-human-brain/
Cubresa Appoints Mr. Jonathan Li as Vice President of Research and Development, and Ms. Lisa Bako as Vice President of Sales and Strategic Partnerships
Monday, October 25th, 2021 PRESS RELEASE Cubresa Appoints Mr. Jonathan Li as Vice President of Research and Development, and Ms. Lisa Bako as Vice President of Sales and Strategic Partnerships Winnipeg, MB – October 25th, 2021 – Cubresa Inc., a world leader in the design and development of PET insert systems for MRI, is announcing two
Cubresa Enters into BrainPET Technology License Agreement with the Sino Canadian Health Institute
Wednesday, October 20th, 2021 PRESS RELEASE Cubresa Enters into BrainPET Technology License Agreement with the Sino Canadian Health Institute Winnipeg, MB – October 20th, 2021 – Cubresa Inc., a world leader in the design and development of PET Insert systems for MRI, and the Sino Canadian Health Institute (SCHI), a Canadian based wholly owned subsidiary of
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
Products
Clinical:
Preclinical:
Contact
Request more information